what is a glp-1 injection pens Agents' Risks and Benefits Broader Than Previously Thought What to do if you

doi: 10.1016/j.neulet.2022.136741 214 WenC.XieT.PanK.DengY.ZhaoZ.LiN.et al

This threefold activity has been associated with significant weight loss (up to 24% of body weight in 6 months) in clinical trials

Ensuring Healthy Weight Loss The researchers ultimately conclude that GLP-1 drugs significantly reduce body weight and adiposity, along with a substantial FFM [fat-free mass] loss, but with no clear evidence of CRF enhancement. They remain concerned that this could take a toll on patients metabolic health, healthspan/frailty and overall longevity

The risk appears more related to the rate and magnitude of weight loss than to cagrilintide specifically

Start your skincare journey with our classics

Clinical advances and ongoing trials on mRNA vaccines for cancer treatment